US Stock MarketDetailed Quotes

CMMB Chemomab Therapeutics

Watchlist
  • 1.367
  • +0.067+5.13%
Trading Mar 5 09:53 ET
25.77MMarket Cap-1.45P/E (TTM)

Chemomab Therapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(FY)Dec 31, 2024
(Q4)Dec 31, 2024
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
Total revenue
0
0
0
0
0
0
0
0
0
0
Operating revenue
--0
--0
--0
--0
--0
--0
--0
--0
--0
--0
Cost of revenue
Gross profit
Operating expense
-42.11%14.74M
-16.50%3.21M
-15.04%3.71M
-54.02%3.77M
-55.27%4.05M
-10.77%25.46M
-55.47%3.85M
-47.49%4.37M
31.04%8.2M
70.09%9.05M
Selling and administrative expenses
-51.79%3.41M
6.79%802K
-11.72%874K
-73.54%840K
-56.71%936K
-38.75%7.08M
-72.66%751K
-65.79%990K
-4.94%3.18M
-16.04%2.16M
-General and administrative expense
-51.79%3.41M
6.79%802K
-11.72%874K
-73.54%840K
-56.71%936K
-38.75%7.08M
-72.66%751K
-65.79%990K
-4.94%3.18M
-16.04%2.16M
Research and development costs
-38.38%11.33M
-22.15%2.41M
-16.02%2.84M
-41.67%2.93M
-54.81%3.11M
8.27%18.38M
-47.46%3.1M
-37.73%3.38M
72.27%5.02M
150.89%6.89M
Operating profit
42.11%-14.74M
16.50%-3.21M
15.04%-3.71M
54.02%-3.77M
55.27%-4.05M
10.77%-25.46M
55.47%-3.85M
47.49%-4.37M
-31.04%-8.2M
-70.09%-9.05M
Net non-operating interest income expense
-35.86%794K
-42.00%250K
-1.73%227K
-47.10%137K
-43.22%180K
250.71%1.24M
13.42%431K
-2.53%231K
153.96%259K
46.76%317K
Total other finance cost
35.86%-794K
42.00%-250K
1.73%-227K
47.10%-137K
43.22%-180K
-250.71%-1.24M
-13.42%-431K
2.53%-231K
-153.96%-259K
-46.76%-317K
Other net income (expense)
Income before tax
42.43%-13.95M
13.29%-2.96M
15.79%-3.48M
54.25%-3.63M
55.70%-3.87M
14.05%-24.22M
58.64%-3.42M
48.81%-4.14M
-17.85%-7.94M
-71.08%-8.73M
Income tax
0
0
0
0
0
-55K
106.25%34K
21K
Net income
42.43%-13.95M
13.29%-2.96M
14.65%-3.48M
54.44%-3.63M
55.81%-3.87M
12.39%-24.22M
58.69%-3.42M
49.49%-4.08M
-28.76%-7.97M
-71.49%-8.75M
Net income continuous Operations
42.43%-13.95M
13.29%-2.96M
14.65%-3.48M
54.44%-3.63M
55.81%-3.87M
12.39%-24.22M
58.69%-3.42M
49.49%-4.08M
-28.76%-7.97M
-71.49%-8.75M
Minority interest income
Net income attributable to the parent company
42.43%-13.95M
13.29%-2.96M
14.65%-3.48M
54.44%-3.63M
55.81%-3.87M
12.39%-24.22M
58.69%-3.42M
49.49%-4.08M
-28.76%-7.97M
-71.49%-8.75M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
42.43%-13.95M
13.29%-2.96M
14.65%-3.48M
54.44%-3.63M
55.81%-3.87M
12.39%-24.22M
58.69%-3.42M
49.49%-4.08M
-28.76%-7.97M
-71.49%-8.75M
Basic earnings per share
58.25%-0.86
27.27%-0.16
41.18%-0.2
63.89%-0.26
65.00%-0.28
14.88%-2.06
69.44%-0.22
51.43%-0.34
-33.33%-0.72
-81.82%-0.8
Diluted earnings per share
58.25%-0.86
27.27%-0.16
41.18%-0.2
63.89%-0.26
65.00%-0.28
14.88%-2.06
69.44%-0.22
51.43%-0.34
-33.33%-0.72
-81.82%-0.8
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
(FY)Dec 31, 2024(Q4)Dec 31, 2024(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023
Total revenue 0000000000
Operating revenue --0--0--0--0--0--0--0--0--0--0
Cost of revenue
Gross profit
Operating expense -42.11%14.74M-16.50%3.21M-15.04%3.71M-54.02%3.77M-55.27%4.05M-10.77%25.46M-55.47%3.85M-47.49%4.37M31.04%8.2M70.09%9.05M
Selling and administrative expenses -51.79%3.41M6.79%802K-11.72%874K-73.54%840K-56.71%936K-38.75%7.08M-72.66%751K-65.79%990K-4.94%3.18M-16.04%2.16M
-General and administrative expense -51.79%3.41M6.79%802K-11.72%874K-73.54%840K-56.71%936K-38.75%7.08M-72.66%751K-65.79%990K-4.94%3.18M-16.04%2.16M
Research and development costs -38.38%11.33M-22.15%2.41M-16.02%2.84M-41.67%2.93M-54.81%3.11M8.27%18.38M-47.46%3.1M-37.73%3.38M72.27%5.02M150.89%6.89M
Operating profit 42.11%-14.74M16.50%-3.21M15.04%-3.71M54.02%-3.77M55.27%-4.05M10.77%-25.46M55.47%-3.85M47.49%-4.37M-31.04%-8.2M-70.09%-9.05M
Net non-operating interest income expense -35.86%794K-42.00%250K-1.73%227K-47.10%137K-43.22%180K250.71%1.24M13.42%431K-2.53%231K153.96%259K46.76%317K
Total other finance cost 35.86%-794K42.00%-250K1.73%-227K47.10%-137K43.22%-180K-250.71%-1.24M-13.42%-431K2.53%-231K-153.96%-259K-46.76%-317K
Other net income (expense)
Income before tax 42.43%-13.95M13.29%-2.96M15.79%-3.48M54.25%-3.63M55.70%-3.87M14.05%-24.22M58.64%-3.42M48.81%-4.14M-17.85%-7.94M-71.08%-8.73M
Income tax 00000-55K106.25%34K21K
Net income 42.43%-13.95M13.29%-2.96M14.65%-3.48M54.44%-3.63M55.81%-3.87M12.39%-24.22M58.69%-3.42M49.49%-4.08M-28.76%-7.97M-71.49%-8.75M
Net income continuous Operations 42.43%-13.95M13.29%-2.96M14.65%-3.48M54.44%-3.63M55.81%-3.87M12.39%-24.22M58.69%-3.42M49.49%-4.08M-28.76%-7.97M-71.49%-8.75M
Minority interest income
Net income attributable to the parent company 42.43%-13.95M13.29%-2.96M14.65%-3.48M54.44%-3.63M55.81%-3.87M12.39%-24.22M58.69%-3.42M49.49%-4.08M-28.76%-7.97M-71.49%-8.75M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders 42.43%-13.95M13.29%-2.96M14.65%-3.48M54.44%-3.63M55.81%-3.87M12.39%-24.22M58.69%-3.42M49.49%-4.08M-28.76%-7.97M-71.49%-8.75M
Basic earnings per share 58.25%-0.8627.27%-0.1641.18%-0.263.89%-0.2665.00%-0.2814.88%-2.0669.44%-0.2251.43%-0.34-33.33%-0.72-81.82%-0.8
Diluted earnings per share 58.25%-0.8627.27%-0.1641.18%-0.263.89%-0.2665.00%-0.2814.88%-2.0669.44%-0.2251.43%-0.34-33.33%-0.72-81.82%-0.8
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP

Trending Stocks

Top Gaining Chinese Stocks Top Gaining Chinese Stocks
No. Symbol % Chg
LEETRO
430425
+29.97%
Geovis Insighter Technology
920116
+23.98%
Beijing Global Safety Technology
300523
+20.01%
4
Zhejiang JW Precision Machinery
300984
+20.00%
5
Wintao Communications
301139
+20.00%
Log In for the Full List
Unlock Now
Investment Course
Top 5 Industries for Stock Trading under Trump's Second Term
Stocks & Industries to Watch Under Trump's Second Presidency
With mooomoo, find out which stocks and industries may benefit from Trump's second presidency, based on his first administration's track record.
Discussing
Trump 2.0 Era: How will global markets evolve?
🎙️Discussion: 1. How will tariff policies affect the movement of key assets such as U.S. stocks, gold, and Bitcoin? 2. Given this context, Show More
MicroStrategy Q4 2024 earnings conference call
Earnings Season Underway
Earnings season is here. What to know?